News

Deal Announcements

CardioMind Clears $33 Million Series C Round

Friday, July 6, 2007 5:00:00 AM PDT | VentureDeal Staff
SUNNYVALE, CA -- Stent development company CardioMind received $33 million in third round funding, according to a report by PE Hub.

CardioMind is still in stealth mode, even after three full rounds of venture capital financing.  All that is publicly known about the company is that it is developing next generation stent technologies.

Investors in the round included SV Life Sciences, De Novo Ventures, InterWest Partners, Latterell Venture Partners, Morgenthaler Ventures and Onset Ventures.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1